Inborn Errors of Metabolism Screening in Neonates: Current Perspective with Diagnosis and Therapy
- PMID:35379134
- DOI: 10.2174/1573396318666220404194452
Inborn Errors of Metabolism Screening in Neonates: Current Perspective with Diagnosis and Therapy
Abstract
Inborn errors of metabolism (IEMs) are rare hereditary or acquired disorders resulting from an enzymatic deformity in biochemical and metabolic pathways influencing proteins, fats, carbohydrate metabolism, or hampered some organelle function. Even though individual IEMs are uncommon, together, they represent a diverse class of genetic diseases, with new issues and disease mechanisms being portrayed consistently. IEM includes the extraordinary multifaceted nature of the fundamental pathophysiology, biochemical diagnosis, molecular level investigation, and complex therapeutic choices. However, due to the molecular, biochemical, and clinical heterogeneity of IEM, screening alone will not detect and diagnose all illnesses included in newborn screening programs. Early diagnosis prevents the emergence of severe clinical symptoms in the majority of IEM cases, lowering morbidity and death. The appearance of IEM disease can vary from neonates to adult people, with the more serious conditions showing up in juvenile stages along with significant morbidity as well as mortality. Advances in understanding the physiological, biochemical, and molecular etiologies of numerous IEMs by means of modalities, for instance, the latest molecular-genetic technologies, genome engineering knowledge, entire exome sequencing, and metabolomics, have prompted remarkable advancement in detection and treatment in modern times. In this review, we analyze the biochemical basis of IEMs, clinical manifestations, the present status of screening, ongoing advances, and efficiency of diagnosis in treatment for IEMs, along with prospects for further exploration as well as innovation.
Keywords: Inborn errors of metabolism; biochemical diagnosis; clinical manifestations; metabolomics; molecular level investigation; neonatal screening.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
- Inborn Errors of Metabolism: Advances in Diagnosis and Therapy.Vernon HJ.Vernon HJ.JAMA Pediatr. 2015 Aug;169(8):778-82. doi: 10.1001/jamapediatrics.2015.0754.JAMA Pediatr. 2015.PMID:26075348Review.
- A comprehensive multiplex PCR based exome-sequencing assay for rapid bloodspot confirmation of inborn errors of metabolism.Wang W, Yang J, Xue J, Mu W, Zhang X, Wu W, Xu M, Gong Y, Liu Y, Zhang Y, Xie X, Gu W, Bai J, Cram DS.Wang W, et al.BMC Med Genet. 2019 Jan 6;20(1):3. doi: 10.1186/s12881-018-0731-5.BMC Med Genet. 2019.PMID:30612563Free PMC article.
- Next-generation metabolic screening: targeted and untargeted metabolomics for the diagnosis of inborn errors of metabolism in individual patients.Coene KLM, Kluijtmans LAJ, van der Heeft E, Engelke UFH, de Boer S, Hoegen B, Kwast HJT, van de Vorst M, Huigen MCDG, Keularts IMLW, Schreuder MF, van Karnebeek CDM, Wortmann SB, de Vries MC, Janssen MCH, Gilissen C, Engel J, Wevers RA.Coene KLM, et al.J Inherit Metab Dis. 2018 May;41(3):337-353. doi: 10.1007/s10545-017-0131-6. Epub 2018 Feb 16.J Inherit Metab Dis. 2018.PMID:29453510Free PMC article.
- Inborn Errors of Metabolism Overview: Pathophysiology, Manifestations, Evaluation, and Management.Saudubray JM, Garcia-Cazorla À.Saudubray JM, et al.Pediatr Clin North Am. 2018 Apr;65(2):179-208. doi: 10.1016/j.pcl.2017.11.002.Pediatr Clin North Am. 2018.PMID:29502909Review.
- The role of exome sequencing in newborn screening for inborn errors of metabolism.Adhikari AN, Gallagher RC, Wang Y, Currier RJ, Amatuni G, Bassaganyas L, Chen F, Kundu K, Kvale M, Mooney SD, Nussbaum RL, Randi SS, Sanford J, Shieh JT, Srinivasan R, Sunderam U, Tang H, Vaka D, Zou Y, Koenig BA, Kwok PY, Risch N, Puck JM, Brenner SE.Adhikari AN, et al.Nat Med. 2020 Sep;26(9):1392-1397. doi: 10.1038/s41591-020-0966-5. Epub 2020 Aug 10.Nat Med. 2020.PMID:32778825Free PMC article.
Cited by
- Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).Therrell BL, Padilla CD, Borrajo GJC, Khneisser I, Schielen PCJI, Knight-Madden J, Malherbe HL, Kase M.Therrell BL, et al.Int J Neonatal Screen. 2024 May 23;10(2):38. doi: 10.3390/ijns10020038.Int J Neonatal Screen. 2024.PMID:38920845Free PMC article.Review.
- Incidence and genetic variants of inborn errors of metabolism identified through newborn screening: A 7-year study in eastern coastal areas of China.Men S, Liu S, Zheng Q, Yang S, Mao H, Wang Z, Gu Y, Tang X, Wang L.Men S, et al.Mol Genet Genomic Med. 2023 Jun;11(6):e2152. doi: 10.1002/mgg3.2152. Epub 2023 Feb 14.Mol Genet Genomic Med. 2023.PMID:36787440Free PMC article.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources